| GO(Gene Ontology) name | FDR corrected p-value |
|---|
| anatomical structure morphogenesis (GO:0009653) | 0 |
| organelle part (GO:0044422) | 0 |
| developmental process (GO:0032502) | 0 |
| cell part (GO:0044464) | 0 |
| multicellular organismal process (GO:0032501) | 0 |
| multicellular organismal development (GO:0007275) | 0 |
| cytoplasmic part (GO:0044444) | 0 |
| intracellular part (GO:0044424) | 0 |
| intracellular (GO:0005622) | 0 |
| organelle (GO:0043226) | 0 |
| organ development (GO:0048513) | 0 |
| regulation of biological process (GO:0050789) | 0 |
| intracellular membrane-bound organelle (GO:0043231) | 0 |
| cellular developmental process (GO:0048869) | 0 |
| system development (GO:0048731) | 0 |
| cytoplasm (GO:0005737) | 0 |
| anatomical structure development (GO:0048856) | 0 |
| biological regulation (GO:0065007) | 0 |
| intracellular organelle (GO:0043229) | 0 |
| membrane-bound organelle (GO:0043227) | 0 |
| cell differentiation (GO:0030154) | 0 |
| protein binding (GO:0005515) | 0 |
| nervous system development (GO:0007399) | 0 |
| membrane (GO:0016020) | 0 |
| organelle membrane (GO:0031090) | 1.09641999397129e-85 |
| intracellular organelle part (GO:0044446) | 1.67468716903664e-85 |
| membrane part (GO:0044425) | 2.38505223534367e-84 |
| plasma membrane part (GO:0044459) | 1.08005889935575e-70 |
| cellular component organization and biogenesis (GO:0016043) | 1.07266100122463e-69 |
| plasma membrane (GO:0005886) | 8.42284128235666e-69 |
| regulation of cellular process (GO:0050794) | 1.45809871015015e-68 |
| cell fraction (GO:0000267) | 3.98329935184088e-64 |
| intrinsic to membrane (GO:0031224) | 1.74845463971239e-63 |
| integral to membrane (GO:0016021) | 2.80282585039429e-62 |
| Golgi apparatus (GO:0005794) | 4.280479574661e-62 |
| endomembrane system (GO:0012505) | 3.74530036384232e-60 |
| cell development (GO:0048468) | 3.28515240213133e-59 |
| intrinsic to plasma membrane (GO:0031226) | 4.69452477081599e-57 |
| membrane fraction (GO:0005624) | 7.75157890026463e-57 |
| integral to plasma membrane (GO:0005887) | 1.07339186851383e-54 |
| negative regulation of biological process (GO:0048519) | 7.000195137743e-53 |
| localization (GO:0051179) | 1.64407024528969e-51 |
| negative regulation of cellular process (GO:0048523) | 2.09795755192771e-51 |
| positive regulation of biological process (GO:0048518) | 4.79862543132678e-51 |
| nucleus (GO:0005634) | 3.91481015657388e-50 |
| localization of cell (GO:0051674) | 5.01362504181169e-50 |
| cell motility (GO:0006928) | 5.01362504181169e-50 |
| positive regulation of cellular process (GO:0048522) | 5.97721935008675e-46 |
| cell junction (GO:0030054) | 1.05025281866757e-44 |
| organ morphogenesis (GO:0009887) | 1.76818934873813e-44 |
| generation of neurons (GO:0048699) | 3.03590474403359e-43 |
| neurogenesis (GO:0022008) | 4.92809132064844e-43 |
| cell morphogenesis (GO:0000902) | 6.18503368808626e-43 |
| cellular structure morphogenesis (GO:0032989) | 6.18503368808626e-43 |
| transcription from RNA polymerase II promoter (GO:0006366) | 7.24843266145962e-40 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 1.67973114430062e-39 |
| cell-cell signaling (GO:0007267) | 3.16297166136798e-39 |
| cell projection (GO:0042995) | 5.17211755760408e-39 |
| Golgi apparatus part (GO:0044431) | 1.44689762707479e-38 |
| vesicle (GO:0031982) | 2.01527490064933e-38 |
| endoplasmic reticulum (GO:0005783) | 3.1982100699622e-38 |
| cell migration (GO:0016477) | 1.07764073696565e-37 |
| cytoplasmic vesicle (GO:0031410) | 1.51310531472263e-37 |
| endoplasmic reticulum part (GO:0044432) | 3.83005566034435e-37 |
| cytoskeleton (GO:0005856) | 5.3732704329311e-37 |
| neuron differentiation (GO:0030182) | 1.14255144648994e-35 |
| central nervous system development (GO:0007417) | 4.8941531133542e-35 |
| Golgi membrane (GO:0000139) | 2.1059538726434e-34 |
| cell communication (GO:0007154) | 2.18044064537273e-34 |
| membrane-bound vesicle (GO:0031988) | 5.1842186953838e-34 |
| primary metabolic process (GO:0044238) | 4.19935625569126e-33 |
| cell proliferation (GO:0008283) | 9.31180618913833e-33 |
| cytoplasmic membrane-bound vesicle (GO:0016023) | 1.088815554384e-32 |
| transmission of nerve impulse (GO:0019226) | 2.3240967583224e-32 |
| mitochondrion (GO:0005739) | 3.22342439543047e-32 |
| magnesium ion binding (GO:0000287) | 1.55768888376194e-30 |
| neuron development (GO:0048666) | 9.50172619448044e-30 |
| cell projection organization and biogenesis (GO:0030030) | 2.42021230920462e-29 |
| cell projection morphogenesis (GO:0048858) | 2.42021230920462e-29 |
| cell part morphogenesis (GO:0032990) | 2.42021230920462e-29 |
| cellular metabolic process (GO:0044237) | 2.87412258116221e-29 |
| cellular lipid metabolic process (GO:0044255) | 5.87376376901783e-29 |
| lipid metabolic process (GO:0006629) | 7.43211506132024e-29 |
| endoplasmic reticulum membrane (GO:0005789) | 9.8045045735391e-29 |
| nuclear envelope-endoplasmic reticulum network (GO:0042175) | 1.34039762175626e-28 |
| establishment of localization (GO:0051234) | 1.39429027220684e-28 |
| regulation of metabolic process (GO:0019222) | 1.968754206884e-28 |
| biopolymer metabolic process (GO:0043283) | 1.66070149262551e-27 |
| synaptic transmission (GO:0007268) | 2.1488309204714e-27 |
| transport (GO:0006810) | 3.56900471414465e-27 |
| membrane organization and biogenesis (GO:0016044) | 4.29543755248263e-27 |
| ion binding (GO:0043167) | 5.48804819242707e-27 |
| vasculature development (GO:0001944) | 8.50303075803332e-27 |
| endosome (GO:0005768) | 1.045800341673e-26 |
| transcription factor binding (GO:0008134) | 1.97196740544042e-26 |
| identical protein binding (GO:0042802) | 2.0083252071521e-26 |
| blood vessel development (GO:0001568) | 2.08959757749713e-26 |
| intracellular signaling cascade (GO:0007242) | 7.31125274764083e-26 |
| metal ion binding (GO:0046872) | 1.16292949170273e-25 |
| alkali metal ion binding (GO:0031420) | 1.72650263218645e-25 |
| neurite development (GO:0031175) | 2.25606170556924e-25 |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 2.26108225018777e-25 |
| cellular morphogenesis during differentiation (GO:0000904) | 2.99245852425409e-25 |
| negative regulation of metabolic process (GO:0009892) | 3.30523550044145e-25 |
| pattern specification process (GO:0007389) | 7.61014417700294e-25 |
| protein modification process (GO:0006464) | 9.22355823336047e-25 |
| regulation of biological quality (GO:0065008) | 9.59851250084171e-25 |
| post-translational protein modification (GO:0043687) | 1.31545261545147e-24 |
| regulation of cellular metabolic process (GO:0031323) | 2.24328796166735e-24 |
| ubiquitin cycle (GO:0006512) | 3.3060962723045e-24 |
| vesicle-mediated transport (GO:0016192) | 3.47588000227678e-24 |
| embryonic development (GO:0009790) | 3.75756532798549e-24 |
| cell death (GO:0008219) | 3.82843329762938e-24 |
| death (GO:0016265) | 3.82843329762938e-24 |
| neuron morphogenesis during differentiation (GO:0048667) | 4.63244382610762e-24 |
| neurite morphogenesis (GO:0048812) | 4.63244382610762e-24 |
| biopolymer modification (GO:0043412) | 6.18706955623022e-24 |
| actin cytoskeleton (GO:0015629) | 3.21201706526508e-23 |
| organelle lumen (GO:0043233) | 3.27870771214935e-23 |
| membrane-enclosed lumen (GO:0031974) | 3.27870771214935e-23 |
| brain development (GO:0007420) | 5.61569072427044e-23 |
| negative regulation of transcription (GO:0016481) | 1.02860975098006e-22 |
| lipid biosynthetic process (GO:0008610) | 3.0082912165385e-22 |
| positive regulation of metabolic process (GO:0009893) | 4.38667551202754e-22 |
| apical part of cell (GO:0045177) | 4.84067201596212e-22 |
| signal transduction (GO:0007165) | 8.48764042473205e-22 |
| axonogenesis (GO:0007409) | 1.05658958286785e-21 |
| regulation of gene expression (GO:0010468) | 1.35738314385434e-21 |
| RNA biosynthetic process (GO:0032774) | 1.50687892269477e-21 |
| transcription, DNA-dependent (GO:0006351) | 1.58125857198027e-21 |
| mitochondrial part (GO:0044429) | 2.58277867879069e-21 |
| protein kinase cascade (GO:0007243) | 2.95842274055852e-21 |
| regulation of cell proliferation (GO:0042127) | 3.03431396452796e-21 |
| negative regulation of cellular metabolic process (GO:0031324) | 3.90606314369264e-21 |
| programmed cell death (GO:0012501) | 3.90606314369264e-21 |
| cytoskeletal protein binding (GO:0008092) | 4.74241526572855e-21 |
| regulation of transcription, DNA-dependent (GO:0006355) | 9.09831996370484e-21 |
| negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0045934) | 1.31146983019882e-20 |
| blood vessel morphogenesis (GO:0048514) | 1.40699849979204e-20 |
| muscle contraction (GO:0006936) | 2.27136368481127e-20 |
| muscle system process (GO:0003012) | 2.27136368481127e-20 |
| microtubule cytoskeleton (GO:0015630) | 3.38477830447234e-20 |
| apoptosis (GO:0006915) | 4.00518429286216e-20 |
| potassium ion binding (GO:0030955) | 4.40817433503762e-20 |
| transcription repressor activity (GO:0016564) | 6.45983470939583e-20 |
| regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0019219) | 8.00426709015336e-20 |
| RNA metabolic process (GO:0016070) | 8.3315667418252e-20 |
| endocytosis (GO:0006897) | 1.34213078692258e-19 |
| membrane invagination (GO:0010324) | 1.34213078692258e-19 |
| Wnt receptor signaling pathway (GO:0016055) | 2.99155719387706e-19 |
| regionalization (GO:0003002) | 3.79400074128488e-19 |
| macromolecule localization (GO:0033036) | 6.52564416341269e-19 |
| regulation of transcription (GO:0045449) | 6.52564416341269e-19 |
| macromolecule metabolic process (GO:0043170) | 8.70117656185561e-19 |
| cation binding (GO:0043169) | 9.02564002876617e-19 |
| manganese ion binding (GO:0030145) | 1.00622784908385e-18 |
| positive regulation of transcription (GO:0045941) | 1.23576380617241e-18 |
| organelle organization and biogenesis (GO:0006996) | 1.27244977920292e-18 |
| calmodulin binding (GO:0005516) | 1.75528796011642e-18 |
| cytoskeleton organization and biogenesis (GO:0007010) | 2.36496315748837e-18 |
| positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0045935) | 2.52100982103091e-18 |
| transcription cofactor activity (GO:0003712) | 3.3839190996914e-18 |
| transcription (GO:0006350) | 3.64045384948645e-18 |
| positive regulation of cellular metabolic process (GO:0031325) | 4.08035623277255e-18 |
| protein localization (GO:0008104) | 5.56725984697247e-18 |
| muscle development (GO:0007517) | 7.60833952556838e-18 |
| coated pit (GO:0005905) | 1.95373155187145e-17 |
| positive regulation of transcription, DNA-dependent (GO:0045893) | 2.05485376477635e-17 |
| biological adhesion (GO:0022610) | 2.39057254131354e-17 |
| cell adhesion (GO:0007155) | 2.39057254131354e-17 |
| actin filament-based process (GO:0030029) | 3.74572239990265e-17 |
| protein dimerization activity (GO:0046983) | 7.45924808355765e-17 |
| intercellular junction (GO:0005911) | 8.29638536682162e-17 |
| tube development (GO:0035295) | 1.27845749739259e-16 |
| transcription activator activity (GO:0016563) | 1.51859133323269e-16 |
| anatomical structure formation (GO:0048646) | 2.26488199813394e-16 |
| proteinaceous extracellular matrix (GO:0005578) | 5.23077800404745e-16 |
| apical plasma membrane (GO:0016324) | 6.39325781113797e-16 |
| organic acid metabolic process (GO:0006082) | 7.3656366654453e-16 |
| regulation of developmental process (GO:0050793) | 8.06217728888478e-16 |
| carboxylic acid metabolic process (GO:0019752) | 1.01552197339842e-15 |
| heart development (GO:0007507) | 1.53865558606097e-15 |
| transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 1.58249432188328e-15 |
| negative regulation of transcription, DNA-dependent (GO:0045892) | 2.22228171100617e-15 |
| tissue development (GO:0009888) | 2.39478827752982e-15 |
| actin cytoskeleton organization and biogenesis (GO:0030036) | 2.39478827752982e-15 |
| clathrin-coated vesicle (GO:0030136) | 2.79460910161061e-15 |
| angiogenesis (GO:0001525) | 2.87034169400983e-15 |
| skeletal development (GO:0001501) | 5.1350092786874e-15 |
| organelle envelope (GO:0031967) | 7.15723484657766e-15 |
| mitochondrial envelope (GO:0005740) | 8.15892111171811e-15 |
| cytoskeletal part (GO:0044430) | 8.96282528548613e-15 |
| envelope (GO:0031975) | 1.04277225807157e-14 |
| protein complex assembly (GO:0006461) | 1.05557907009208e-14 |
| MAPKKK cascade (GO:0000165) | 1.34649832256205e-14 |
| sterol metabolic process (GO:0016125) | 1.56541656771254e-14 |
| neuron projection (GO:0043005) | 1.57569661855811e-14 |
| establishment of protein localization (GO:0045184) | 1.58589466657824e-14 |
| mitochondrial membrane (GO:0031966) | 1.64873391446314e-14 |
| calcium ion binding (GO:0005509) | 1.70072406640598e-14 |
| regulation of neurotransmitter levels (GO:0001505) | 1.78413322112527e-14 |
| monocarboxylic acid metabolic process (GO:0032787) | 2.28893789540523e-14 |
| extracellular region part (GO:0044421) | 2.49141938153989e-14 |
| enzyme binding (GO:0019899) | 3.07683161051643e-14 |
| secretion (GO:0046903) | 3.32114241408495e-14 |
| gamete generation (GO:0007276) | 4.64065037772864e-14 |
| fatty acid metabolic process (GO:0006631) | 4.70692949398781e-14 |
| cellular localization (GO:0051641) | 5.62706597716196e-14 |
| endosomal part (GO:0044440) | 5.76131647391772e-14 |
| endosome membrane (GO:0010008) | 5.76131647391772e-14 |
| establishment of cellular localization (GO:0051649) | 8.3836357159898e-14 |
| protein homodimerization activity (GO:0042803) | 9.86807326215498e-14 |
| coated vesicle (GO:0030135) | 1.12734140971106e-13 |
| response to chemical stimulus (GO:0042221) | 1.12734140971106e-13 |
| axon guidance (GO:0007411) | 1.56763675641345e-13 |
| sexual reproduction (GO:0019953) | 1.56763675641345e-13 |
| protein transport (GO:0015031) | 2.83262597912827e-13 |
| nuclear part (GO:0044428) | 5.76998870219773e-13 |
| sensory organ development (GO:0007423) | 5.94487456130645e-13 |
| microtubule organizing center (GO:0005815) | 6.64834857865072e-13 |
| embryonic morphogenesis (GO:0048598) | 6.99657508385564e-13 |
| centrosome (GO:0005813) | 9.17803193015586e-13 |
| cell surface (GO:0009986) | 1.04771299757597e-12 |
| cytosol (GO:0005829) | 1.1852480211546e-12 |
| reproductive process (GO:0022414) | 1.24311556095868e-12 |
| blood circulation (GO:0008015) | 1.28581451877122e-12 |
| circulatory system process (GO:0003013) | 1.28581451877122e-12 |
| catabolic process (GO:0009056) | 2.17395675628048e-12 |
| cholesterol metabolic process (GO:0008203) | 2.28166406586981e-12 |
| heart contraction (GO:0060047) | 2.28768616123836e-12 |
| heart process (GO:0003015) | 2.28768616123836e-12 |
| leading edge (GO:0031252) | 3.3547721199184e-12 |
| regulation of cell motility (GO:0051270) | 3.98456886170616e-12 |
| sodium ion binding (GO:0031402) | 4.3994710619276e-12 |
| regulation of heart contraction (GO:0008016) | 4.82943030949437e-12 |
| regulation of programmed cell death (GO:0043067) | 4.87029066502902e-12 |
| response to stress (GO:0006950) | 5.19056936246216e-12 |
| male gamete generation (GO:0048232) | 5.51361665783038e-12 |
| spermatogenesis (GO:0007283) | 5.51361665783038e-12 |
| peroxisome (GO:0005777) | 5.72850926539485e-12 |
| microbody (GO:0042579) | 5.72850926539485e-12 |
| regulation of cell migration (GO:0030334) | 5.72850926539485e-12 |
| microtubule (GO:0005874) | 6.32710563643881e-12 |
| carboxylic acid biosynthetic process (GO:0046394) | 6.79581953059385e-12 |
| organic acid biosynthetic process (GO:0016053) | 6.79581953059385e-12 |
| regulation of cell size (GO:0008361) | 1.17775734010535e-11 |
| nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0006139) | 1.2150228125831e-11 |
| secretion by cell (GO:0032940) | 1.5660131966971e-11 |
| anterior/posterior pattern formation (GO:0009952) | 1.57187552877912e-11 |
| cell cycle (GO:0007049) | 1.59923192920674e-11 |
| vacuole (GO:0005773) | 2.11619145095527e-11 |
| regulation of apoptosis (GO:0042981) | 2.11619145095527e-11 |
| cell soma (GO:0043025) | 2.11883897543793e-11 |
| regulation of transport (GO:0051049) | 2.61233210860562e-11 |
| apical junction complex (GO:0043296) | 3.00297549711212e-11 |
| organelle inner membrane (GO:0019866) | 3.03227733475485e-11 |
| metal ion transport (GO:0030001) | 3.4075266455357e-11 |
| regulation of locomotion (GO:0040012) | 3.41499872285262e-11 |
| regulation of growth (GO:0040008) | 3.47408289119853e-11 |
| transcription corepressor activity (GO:0003714) | 3.60783286927352e-11 |
| nitrogen compound metabolic process (GO:0006807) | 3.9294946696499e-11 |
| transport vesicle (GO:0030133) | 6.18294857675022e-11 |
| regulation of a molecular function (GO:0065009) | 6.23499084084806e-11 |
| locomotion (GO:0040011) | 6.74917552727177e-11 |
| transmembrane receptor protein kinase activity (GO:0019199) | 6.9507078186801e-11 |
| apicolateral plasma membrane (GO:0016327) | 8.46889104126813e-11 |
| positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 8.4689198599702e-11 |
| mitochondrial inner membrane (GO:0005743) | 8.99894649163774e-11 |
| lipid binding (GO:0008289) | 9.27190936688685e-11 |
| regulation of transferase activity (GO:0051338) | 1.0075840525222e-10 |
| tube morphogenesis (GO:0035239) | 1.06954491118214e-10 |
| alcohol metabolic process (GO:0006066) | 1.31923684302884e-10 |
| amine metabolic process (GO:0009308) | 1.32046219078959e-10 |
| embryonic development ending in birth or egg hatching (GO:0009792) | 1.32046219078959e-10 |
| chordate embryonic development (GO:0043009) | 1.32046219078959e-10 |
| cell growth (GO:0016049) | 1.32664045969904e-10 |
| cellular catabolic process (GO:0044248) | 1.34277331452789e-10 |
| regulation of signal transduction (GO:0009966) | 1.59599378710251e-10 |
| structural constituent of cytoskeleton (GO:0005200) | 1.90237317292075e-10 |
| basolateral plasma membrane (GO:0016323) | 1.90237317292075e-10 |
| positive regulation of cell proliferation (GO:0008284) | 2.55838358845855e-10 |
| system process (GO:0003008) | 2.61211738741281e-10 |
| negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.68094210259117e-10 |
| nucleoplasm (GO:0005654) | 3.97515583984247e-10 |
| nucleoplasm part (GO:0044451) | 4.80601071585712e-10 |
| lysosome (GO:0005764) | 5.0088450722979e-10 |
| steroid metabolic process (GO:0008202) | 5.99744961929585e-10 |
| lytic vacuole (GO:0000323) | 6.81889703075224e-10 |
| regulation of protein kinase activity (GO:0045859) | 7.8046671133626e-10 |
| regulation of kinase activity (GO:0043549) | 9.22198128091153e-10 |
| nuclear lumen (GO:0031981) | 9.30119459072207e-10 |
| synaptic vesicle (GO:0008021) | 1.11577718141953e-09 |
| cell-substrate adhesion (GO:0031589) | 1.20076306840478e-09 |
| regulation of cell growth (GO:0001558) | 1.20961754267191e-09 |
| transcription coactivator activity (GO:0003713) | 1.22745447325323e-09 |
| actin binding (GO:0003779) | 1.236525421379e-09 |
| perinuclear region of cytoplasm (GO:0048471) | 1.27400344115859e-09 |
| RNA polymerase II transcription factor activity (GO:0003702) | 1.27655415817411e-09 |
| mitochondrial lumen (GO:0031980) | 1.29156431804512e-09 |
| mitochondrial matrix (GO:0005759) | 1.29156431804512e-09 |
| late endosome (GO:0005770) | 1.2958403743101e-09 |
| neuron migration (GO:0001764) | 1.48467633025451e-09 |
| lamellipodium (GO:0030027) | 1.61025871159148e-09 |
| lung development (GO:0030324) | 1.63148172412897e-09 |
| regulation of cellular component organization and biogenesis (GO:0051128) | 1.65993751194194e-09 |
| secretory pathway (GO:0045045) | 1.68927051339431e-09 |
| sensory perception of mechanical stimulus (GO:0050954) | 2.76446236716165e-09 |
| sensory perception of sound (GO:0007605) | 2.76446236716165e-09 |
| potassium ion transport (GO:0006813) | 3.35935934931693e-09 |
| membrane lipid biosynthetic process (GO:0046467) | 3.49787869566382e-09 |
| transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178) | 3.54549393384153e-09 |
| soluble fraction (GO:0005625) | 3.56643615955186e-09 |
| respiratory tube development (GO:0030323) | 3.98287148492849e-09 |
| ER-Golgi intermediate compartment (GO:0005793) | 3.98287148492849e-09 |
| cell cycle process (GO:0022402) | 4.40923204662378e-09 |
| fatty acid biosynthetic process (GO:0006633) | 4.76756480205859e-09 |
| regulation of cytoskeleton organization and biogenesis (GO:0051493) | 4.85321944453074e-09 |
| regulation of organelle organization and biogenesis (GO:0033043) | 4.85321944453074e-09 |
| cellular carbohydrate metabolic process (GO:0044262) | 5.60966958163806e-09 |
| cell-matrix adhesion (GO:0007160) | 6.0543377209456e-09 |
| in utero embryonic development (GO:0001701) | 7.0929461890471e-09 |
| protein C-terminus binding (GO:0008022) | 8.46569067341435e-09 |
| skeletal muscle development (GO:0007519) | 8.5156394582595e-09 |
| regulation of neurogenesis (GO:0050767) | 1.04572335547386e-08 |
| dendrite (GO:0030425) | 1.04572335547386e-08 |
| intracellular transport (GO:0046907) | 1.20579856358027e-08 |
| vesicle membrane (GO:0012506) | 1.77969917950629e-08 |
| regulation of catalytic activity (GO:0050790) | 1.90431343716728e-08 |
| metal ion transmembrane transporter activity (GO:0046873) | 1.95896158985488e-08 |
| pigment granule (GO:0048770) | 2.17860492208382e-08 |
| melanosome (GO:0042470) | 2.17860492208382e-08 |
| transcription factor activity (GO:0003700) | 2.4671084957376e-08 |
| reproductive developmental process (GO:0003006) | 2.51665035960584e-08 |
| regulation of muscle contraction (GO:0006937) | 2.57653594229834e-08 |
| sterol biosynthetic process (GO:0016126) | 2.5768603498112e-08 |
| synaptosome (GO:0019717) | 2.65081495064097e-08 |
| cyclic-nucleotide-mediated signaling (GO:0019935) | 2.67250099313593e-08 |
| lipid transport (GO:0006869) | 3.67314694095408e-08 |
| striated muscle development (GO:0014706) | 4.044384424395e-08 |
| protein autoprocessing (GO:0016540) | 4.53073768681479e-08 |
| forebrain development (GO:0030900) | 4.53073768681479e-08 |
| generation of a signal involved in cell-cell signaling (GO:0003001) | 4.83188845472559e-08 |
| sex differentiation (GO:0007548) | 5.02161254835172e-08 |
| morphogenesis of an epithelium (GO:0002009) | 5.02161254835172e-08 |
| neurotransmitter secretion (GO:0007269) | 6.00919042775938e-08 |
| small protein conjugating enzyme activity (GO:0008639) | 6.2777281855429e-08 |
| steroid biosynthetic process (GO:0006694) | 6.38311807648621e-08 |
| transmembrane receptor protein tyrosine kinase activity (GO:0004714) | 8.31640921330227e-08 |
| G-protein signaling, coupled to cyclic nucleotide second messenger (GO:0007187) | 8.35360727560337e-08 |
| endoplasmic reticulum lumen (GO:0005788) | 8.97013076787092e-08 |
| contractile fiber (GO:0043292) | 8.97013076787092e-08 |
| protein metabolic process (GO:0019538) | 8.97013076787092e-08 |
| sulfur metabolic process (GO:0006790) | 9.10414915162372e-08 |
| regulation of actin cytoskeleton organization and biogenesis (GO:0032956) | 9.31486840591097e-08 |
| cell projection part (GO:0044463) | 9.31486840591097e-08 |
| negative regulation of programmed cell death (GO:0043069) | 1.1020524126704e-07 |
| mesoderm development (GO:0007498) | 1.12552006943528e-07 |
| protein amino acid autophosphorylation (GO:0046777) | 1.12552006943528e-07 |
| adherens junction (GO:0005912) | 1.14289426574392e-07 |
| ubiquitin-protein ligase activity (GO:0004842) | 1.21174924474233e-07 |
| integral to organelle membrane (GO:0031301) | 1.38652744594308e-07 |
| cAMP-mediated signaling (GO:0019933) | 1.42300971781696e-07 |
| negative regulation of apoptosis (GO:0043066) | 1.57001269579636e-07 |
| response to hormone stimulus (GO:0009725) | 1.61614881889004e-07 |
| G-protein signaling, coupled to cAMP nucleotide second messenger (GO:0007188) | 2.05383366845345e-07 |
| cytoplasm organization and biogenesis (GO:0007028) | 2.84995699452395e-07 |
| negative regulation of cell proliferation (GO:0008285) | 2.85863380588356e-07 |
| response to protein stimulus (GO:0051789) | 2.9000422442105e-07 |
| response to unfolded protein (GO:0006986) | 2.9000422442105e-07 |
| diacylglycerol binding (GO:0019992) | 2.9000422442105e-07 |
| phospholipid binding (GO:0005543) | 3.18518963021642e-07 |
| membrane lipid metabolic process (GO:0006643) | 3.23013542409392e-07 |
| positive regulation of programmed cell death (GO:0043068) | 3.26375559722796e-07 |
| induction of apoptosis (GO:0006917) | 3.27230794811889e-07 |
| regulation of MAP kinase activity (GO:0043405) | 3.55780059957422e-07 |
| induction of programmed cell death (GO:0012502) | 4.14776847631411e-07 |
| epidermal growth factor receptor signaling pathway (GO:0007173) | 4.14776847631411e-07 |
| DNA binding (GO:0003677) | 4.3158402189641e-07 |
| tubulin binding (GO:0015631) | 4.48662089537801e-07 |
| protein depolymerization (GO:0051261) | 4.61054179007577e-07 |
| regulation of actin filament length (GO:0030832) | 4.61054179007577e-07 |
| vesicular fraction (GO:0042598) | 4.87365162557639e-07 |
| contractile fiber part (GO:0044449) | 5.03561481217517e-07 |
| positive regulation of apoptosis (GO:0043065) | 5.60712939168173e-07 |
| positive regulation of catalytic activity (GO:0043085) | 5.60712939168173e-07 |
| protein domain specific binding (GO:0019904) | 6.30439195012125e-07 |
| regulation of cell differentiation (GO:0045595) | 6.44443510009003e-07 |
| voltage-gated potassium channel complex (GO:0008076) | 6.64569460317792e-07 |
| transforming growth factor beta receptor signaling pathway (GO:0007179) | 6.76676923801541e-07 |
| aminoglycan metabolic process (GO:0006022) | 6.76676923801541e-07 |
| Notch signaling pathway (GO:0007219) | 6.76676923801541e-07 |
| embryonic pattern specification (GO:0009880) | 7.39541089506731e-07 |
| cytoplasmic vesicle part (GO:0044433) | 7.68580215625423e-07 |
| kinase binding (GO:0019900) | 7.84274884955259e-07 |
| protein serine/threonine kinase activity (GO:0004674) | 8.09149544239773e-07 |
| eye development (GO:0001654) | 8.78837246834107e-07 |
| regulation of cellular component size (GO:0032535) | 8.78837246834107e-07 |
| second-messenger-mediated signaling (GO:0019932) | 9.22802093902694e-07 |
| camera-type eye development (GO:0043010) | 9.44444711927665e-07 |
| chemical homeostasis (GO:0048878) | 1.01274614082961e-06 |
| regulation of actin polymerization and/or depolymerization (GO:0008064) | 1.12599750596295e-06 |
| learning and/or memory (GO:0007611) | 1.12599750596295e-06 |
| GTPase activity (GO:0003924) | 1.16779826943707e-06 |
| protein complex (GO:0043234) | 1.28601527596491e-06 |
| cation transport (GO:0006812) | 1.29635529783412e-06 |
| voltage-gated channel activity (GO:0022832) | 1.32284299996527e-06 |
| voltage-gated ion channel activity (GO:0005244) | 1.32284299996527e-06 |
| carbohydrate biosynthetic process (GO:0016051) | 1.3405926743704e-06 |
| regulation of axonogenesis (GO:0050770) | 1.35398540027285e-06 |
| positive regulation of transferase activity (GO:0051347) | 1.49294208034738e-06 |
| chromatin modification (GO:0016568) | 1.53459021900172e-06 |
| cytoplasmic vesicle membrane (GO:0030659) | 1.57511221316905e-06 |
| energy reserve metabolic process (GO:0006112) | 1.59945013293568e-06 |
| protein complex binding (GO:0032403) | 1.60876985777329e-06 |
| tight junction (GO:0005923) | 1.61716321793347e-06 |
| homeostatic process (GO:0042592) | 1.62034452348644e-06 |
| intrinsic to organelle membrane (GO:0031300) | 1.76753870997352e-06 |
| cation channel activity (GO:0005261) | 1.9102952267901e-06 |
| sphingolipid biosynthetic process (GO:0030148) | 2.01003585372437e-06 |
| sarcolemma (GO:0042383) | 2.16409242333569e-06 |
| microsome (GO:0005792) | 2.42988790261319e-06 |
| regulation of protein metabolic process (GO:0051246) | 2.53528495946871e-06 |
| ear development (GO:0043583) | 2.73628676930036e-06 |
| skeletal muscle fiber development (GO:0048741) | 2.73628676930036e-06 |
| muscle fiber development (GO:0048747) | 2.73628676930036e-06 |
| glycosaminoglycan metabolic process (GO:0030203) | 2.93158665608369e-06 |
| cell fate commitment (GO:0045165) | 2.93158665608369e-06 |
| potassium channel activity (GO:0005267) | 3.05591314854389e-06 |
| molecular adaptor activity (GO:0060090) | 3.28506060156942e-06 |
| phosphoinositide binding (GO:0035091) | 3.29144742793223e-06 |
| carbohydrate metabolic process (GO:0005975) | 3.52275148403304e-06 |
| ectoderm development (GO:0007398) | 3.7128770497418e-06 |
| myofibril (GO:0030016) | 3.77093816256973e-06 |
| stress-activated protein kinase signaling pathway (GO:0031098) | 4.19760046624122e-06 |
| sphingolipid metabolic process (GO:0006665) | 4.19760046624122e-06 |
| channel regulator activity (GO:0016247) | 4.27314898246952e-06 |
| negative regulation of signal transduction (GO:0009968) | 4.52504466458201e-06 |
| actin polymerization and/or depolymerization (GO:0008154) | 5.37879373002759e-06 |
| JNK cascade (GO:0007254) | 6.05208404916807e-06 |
| neuroblast proliferation (GO:0007405) | 6.05208404916807e-06 |
| amino acid and derivative metabolic process (GO:0006519) | 6.06434458034427e-06 |
| protein heterodimerization activity (GO:0046982) | 6.3218598329987e-06 |
| regulation of progression through cell cycle (GO:0000074) | 6.58371938947718e-06 |
| protein ubiquitination (GO:0016567) | 6.96410319461636e-06 |
| positive regulation of kinase activity (GO:0033674) | 7.01495588781933e-06 |
| regulation of cell cycle (GO:0051726) | 7.60382852454122e-06 |
| fatty acid oxidation (GO:0019395) | 1.00092181134259e-05 |
| establishment and/or maintenance of cell polarity (GO:0007163) | 1.00092181134259e-05 |
| receptor signaling protein activity (GO:0005057) | 1.02143361425488e-05 |
| positive regulation of protein kinase activity (GO:0045860) | 1.02143361425488e-05 |
| mitotic cell cycle (GO:0000278) | 1.03540258701903e-05 |
| basement membrane (GO:0005604) | 1.05237448669227e-05 |
| protein-tyrosine kinase activity (GO:0004713) | 1.18840442970987e-05 |
| phosphotransferase activity, alcohol group as acceptor (GO:0016773) | 1.20279313932153e-05 |
| intercellular junction assembly and maintenance (GO:0045216) | 1.50681066853256e-05 |
| vasculogenesis (GO:0001570) | 1.50681066853256e-05 |
| voltage-gated potassium channel activity (GO:0005249) | 1.50681066853256e-05 |
| behavior (GO:0007610) | 1.59519474637441e-05 |
| guanyl-nucleotide exchange factor activity (GO:0005085) | 1.62492716839911e-05 |
| cellular homeostasis (GO:0019725) | 1.75463991674801e-05 |
| SNARE binding (GO:0000149) | 1.82698683984308e-05 |
| energy derivation by oxidation of organic compounds (GO:0015980) | 1.86555152322345e-05 |
| development of primary sexual characteristics (GO:0045137) | 1.96392159646278e-05 |
| microtubule associated complex (GO:0005875) | 1.97588369413191e-05 |
| cellular chemical homeostasis (GO:0055082) | 2.07237522800828e-05 |
| cellular ion homeostasis (GO:0006873) | 2.07237522800828e-05 |
| microtubule binding (GO:0008017) | 2.10197286292298e-05 |
| SH3/SH2 adaptor activity (GO:0005070) | 2.10197286292298e-05 |
| transferase activity (GO:0016740) | 2.23056687395064e-05 |
| regulation of tube size (GO:0035150) | 2.2879658803836e-05 |
| regulation of blood vessel size (GO:0050880) | 2.2879658803836e-05 |
| positive regulation of systemic arterial blood pressure (GO:0003084) | 2.39133848448663e-05 |
| ion transport (GO:0006811) | 2.40132799588274e-05 |
| developmental maturation (GO:0021700) | 2.4584295150107e-05 |
| regulated secretory pathway (GO:0045055) | 2.4584295150107e-05 |
| cellular component assembly (GO:0022607) | 2.94240873986366e-05 |
| Golgi vesicle transport (GO:0048193) | 3.03539057433745e-05 |
| response to external stimulus (GO:0009605) | 3.09918742068151e-05 |
| gated channel activity (GO:0022836) | 3.26551584139089e-05 |
| Golgi-associated vesicle (GO:0005798) | 3.29605004013823e-05 |
| receptor signaling protein serine/threonine kinase activity (GO:0004702) | 3.3019872139589e-05 |
| protein modification by small protein conjugation (GO:0032446) | 3.3019872139589e-05 |
| negative regulation of developmental process (GO:0051093) | 3.3019872139589e-05 |
| cell division (GO:0051301) | 3.55506461343265e-05 |
| gastrulation (GO:0007369) | 3.63042488094566e-05 |
| vascular process in circulatory system (GO:0003018) | 4.00182118371979e-05 |
| amino acid derivative metabolic process (GO:0006575) | 4.20443410022305e-05 |
| extrinsic to membrane (GO:0019898) | 4.25585356789178e-05 |
| intercellular junction assembly (GO:0007043) | 4.47221945969214e-05 |
| anti-apoptosis (GO:0006916) | 4.47221945969214e-05 |
| mitochondrial outer membrane (GO:0005741) | 4.59393064704853e-05 |
| protein oligomerization (GO:0051259) | 4.59393064704853e-05 |
| cellular macromolecule metabolic process (GO:0044260) | 4.84289672449202e-05 |
| glycogen metabolic process (GO:0005977) | 4.85365194961666e-05 |
| protein processing (GO:0016485) | 4.99287283714173e-05 |
| ion homeostasis (GO:0050801) | 5.20265697422234e-05 |
| epithelial cell proliferation (GO:0050673) | 5.20265697422234e-05 |
| sensory perception of light stimulus (GO:0050953) | 5.21131906259357e-05 |
| visual perception (GO:0007601) | 5.21131906259357e-05 |
| regulation of action potential (GO:0001508) | 5.40846035843974e-05 |
| protein tetramerization (GO:0051262) | 6.0415732196109e-05 |
| axon extension (GO:0048675) | 6.0415732196109e-05 |
| mesoderm morphogenesis (GO:0048332) | 6.0415732196109e-05 |
| negative regulation of catalytic activity (GO:0043086) | 6.0620713840831e-05 |
| positive regulation of signal transduction (GO:0009967) | 6.0620713840831e-05 |
| GPI anchor binding (GO:0048503) | 6.25480518537131e-05 |
| transcription factor complex (GO:0005667) | 6.75704336007343e-05 |
| monovalent inorganic cation transport (GO:0015672) | 6.76499278026836e-05 |
| ligase activity (GO:0016874) | 6.76794446461199e-05 |
| protein complex scaffold (GO:0032947) | 6.76794446461199e-05 |
| fatty acid beta-oxidation (GO:0006635) | 6.76794446461199e-05 |
| regulation of actin filament depolymerization (GO:0030834) | 6.82356228974559e-05 |
| actin filament depolymerization (GO:0030042) | 6.82356228974559e-05 |
| small GTPase mediated signal transduction (GO:0007264) | 6.85249306736304e-05 |
| extracellular matrix part (GO:0044420) | 7.06025103534448e-05 |
| lipid transporter activity (GO:0005319) | 7.12454453261869e-05 |
| nitrogen compound catabolic process (GO:0044270) | 7.12454453261869e-05 |
| regulation of axon extension (GO:0030516) | 7.1370076059618e-05 |
| negative regulation of progression through cell cycle (GO:0045786) | 7.23700581260154e-05 |
| gene expression (GO:0010467) | 7.66388598758415e-05 |
| response to hypoxia (GO:0001666) | 7.74498028898083e-05 |
| glucan metabolic process (GO:0006073) | 7.74498028898083e-05 |
| voltage-gated cation channel activity (GO:0022843) | 7.93488760026293e-05 |
| cation transmembrane transporter activity (GO:0008324) | 8.28902534397373e-05 |
| negative regulation of cellular component organization and biogenesis (GO:0051129) | 8.66857599519674e-05 |
| integrin binding (GO:0005178) | 9.18631631732376e-05 |
| nuclear hormone receptor binding (GO:0035257) | 9.3467744540066e-05 |
| protein kinase activity (GO:0004672) | 0.000104957236645543 |
| positive regulation of blood pressure (GO:0045777) | 0.0001093997762311 |
| cell maturation (GO:0048469) | 0.000109971029748811 |
| adult behavior (GO:0030534) | 0.000110447861229431 |
| cell cycle phase (GO:0022403) | 0.000110447861229431 |
| exocytosis (GO:0006887) | 0.000124398359714163 |
| UDP-glycosyltransferase activity (GO:0008194) | 0.000125656771148216 |
| determination of symmetry (GO:0009799) | 0.000125656771148216 |
| determination of bilateral symmetry (GO:0009855) | 0.000125656771148216 |
| determination of left/right symmetry (GO:0007368) | 0.000125656771148216 |
| regulation of angiogenesis (GO:0045765) | 0.000125786414005837 |
| inner ear development (GO:0048839) | 0.000125786414005837 |
| response to oxidative stress (GO:0006979) | 0.000126859128176325 |
| protein amino acid phosphorylation (GO:0006468) | 0.000127472022575536 |
| phosphorus metabolic process (GO:0006793) | 0.000128304659026452 |
| phosphate metabolic process (GO:0006796) | 0.000128304659026452 |
| activin receptor activity (GO:0017002) | 0.000136094302091637 |
| recycling endosome membrane (GO:0055038) | 0.000136094302091637 |
| activin binding (GO:0048185) | 0.000136094302091637 |
| carnitine O-acyltransferase activity (GO:0016406) | 0.000136094302091637 |
| amine catabolic process (GO:0009310) | 0.000136758519919971 |
| hormone receptor binding (GO:0051427) | 0.000139583150819261 |
| reproductive process in a multicellular organism (GO:0048609) | 0.000142748067678995 |
| multicellular organism reproduction (GO:0032504) | 0.000142748067678995 |
| structural constituent of muscle (GO:0008307) | 0.000151644211706179 |
| peptidyl-amino acid modification (GO:0018193) | 0.000160629337190833 |
| transition metal ion binding (GO:0046914) | 0.000164262435383301 |
| sphingoid metabolic process (GO:0046519) | 0.000169659042286193 |
| muscle cell differentiation (GO:0042692) | 0.000174329166968619 |
| epidermis development (GO:0008544) | 0.000175584575165689 |
| dorsal/ventral pattern formation (GO:0009953) | 0.000181204669631987 |
| cell-cell adherens junction (GO:0005913) | 0.000186120013760905 |
| N-methyltransferase activity (GO:0008170) | 0.000190938158974491 |
| sodium ion transport (GO:0006814) | 0.00019976296411233 |
| intrinsic to Golgi membrane (GO:0031228) | 0.00020059841148316 |
| kinase regulator activity (GO:0019207) | 0.000203425401200825 |
| intracellular protein transport (GO:0006886) | 0.000209150699596802 |
| biopolymer catabolic process (GO:0043285) | 0.000214659231301837 |
| regulation of multicellular organismal process (GO:0051239) | 0.000220211745463101 |
| GTPase regulator activity (GO:0030695) | 0.000226790855943117 |
| heart morphogenesis (GO:0003007) | 0.000230625819552718 |
| negative regulation of actin filament depolymerization (GO:0030835) | 0.000232066901724815 |
| protein kinase binding (GO:0019901) | 0.000232523756748001 |
| neurotransmitter metabolic process (GO:0042133) | 0.000237535353156686 |
| morphogenesis of a branching structure (GO:0001763) | 0.000237535353156686 |
| transmembrane receptor protein phosphatase activity (GO:0019198) | 0.000240709610056837 |
| transmembrane receptor protein tyrosine phosphatase activity (GO:0005001) | 0.000240709610056837 |
| syntaxin binding (GO:0019905) | 0.000240709610056837 |
| cellular protein metabolic process (GO:0044267) | 0.000247938910572169 |
| extracellular matrix structural constituent (GO:0005201) | 0.000254594918773622 |
| intercalated disc (GO:0014704) | 0.000270666756743377 |
| microbody part (GO:0044438) | 0.000270666756743377 |
| peroxisomal part (GO:0044439) | 0.000270666756743377 |
| G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) (GO:0007200) | 0.000285627813932423 |
| glycolipid metabolic process (GO:0006664) | 0.000288209938561039 |
| trans-Golgi network transport vesicle (GO:0030140) | 0.000288209938561039 |
| gliogenesis (GO:0042063) | 0.000288962682913951 |
| epithelial cell differentiation (GO:0030855) | 0.000288962682913951 |
| regulation of secretion (GO:0051046) | 0.00029976564131197 |
| extracellular structure organization and biogenesis (GO:0043062) | 0.00030961391265127 |
| organelle outer membrane (GO:0031968) | 0.000343712711818201 |
| eye morphogenesis (GO:0048592) | 0.000344510092022493 |
| galactosyltransferase activity (GO:0008378) | 0.000344510092022493 |
| urogenital system development (GO:0001655) | 0.000344510092022493 |
| macromolecular complex assembly (GO:0065003) | 0.00034980143639213 |
| heparin binding (GO:0008201) | 0.000359811414246461 |
| neuromuscular process (GO:0050905) | 0.000400151387376583 |
| protein methyltransferase activity (GO:0008276) | 0.000417444655736354 |
| sarcomere (GO:0030017) | 0.000417444655736354 |
| cAMP binding (GO:0030552) | 0.000421771048169543 |
| sequence-specific DNA binding (GO:0043565) | 0.0004385892298598 |
| regulation of ion transport (GO:0043269) | 0.000456822517431804 |
| positive regulation of cell migration (GO:0030335) | 0.000456822517431804 |
| formation of primary germ layer (GO:0001704) | 0.000456822517431804 |
| endoderm development (GO:0007492) | 0.000508700566695308 |
| wound healing (GO:0042060) | 0.00053974589099615 |
| receptor-mediated endocytosis (GO:0006898) | 0.000556114992632612 |
| actin filament organization (GO:0007015) | 0.000556114992632612 |
| segmentation (GO:0035282) | 0.000556114992632612 |
| negative regulation of protein metabolic process (GO:0051248) | 0.000596484130825821 |
| peroxisomal membrane (GO:0005778) | 0.000603428052750767 |
| microbody membrane (GO:0031903) | 0.000603428052750767 |
| early endosome (GO:0005769) | 0.00063151056553761 |
| protein binding, bridging (GO:0030674) | 0.000651491637942629 |
| axon (GO:0030424) | 0.000684816250752802 |
| ear morphogenesis (GO:0042471) | 0.000693201072925617 |
| positive regulation of catabolic process (GO:0009896) | 0.000733566583723715 |
| adult heart development (GO:0007512) | 0.000733566583723715 |
| fatty acid transport (GO:0015908) | 0.000733566583723715 |
| hindlimb morphogenesis (GO:0035137) | 0.000733566583723715 |
| oxidoreductase activity, acting on NADH or NADPH, heme protein as acceptor (GO:0016653) | 0.000733566583723715 |
| outer membrane (GO:0019867) | 0.000751304603894496 |
| protein kinase regulator activity (GO:0019887) | 0.000752587387492866 |
| tissue remodeling (GO:0048771) | 0.000752587387492866 |
| ER-Golgi intermediate compartment membrane (GO:0033116) | 0.000762834650318005 |
| genitalia development (GO:0048806) | 0.000762834650318005 |
| protein amino acid methylation (GO:0006479) | 0.000762834650318005 |
| positive regulation of locomotion (GO:0040017) | 0.000762834650318005 |
| positive regulation of cell motility (GO:0051272) | 0.000762834650318005 |
| actin filament capping (GO:0051693) | 0.000762834650318005 |
| protein amino acid alkylation (GO:0008213) | 0.000762834650318005 |
| barbed-end actin filament capping (GO:0051016) | 0.000762834650318005 |
| nucleoside-diphosphatase activity (GO:0017110) | 0.000771868980172474 |
| establishment of cell polarity (GO:0030010) | 0.000771868980172474 |
| positive regulation of protein catabolic process (GO:0045732) | 0.000771868980172474 |
| protein-cofactor linkage (GO:0018065) | 0.000771868980172474 |
| vinculin binding (GO:0017166) | 0.000771868980172474 |
| ubiquitin ligase complex (GO:0000151) | 0.000779444206304919 |
| positive regulation of MAP kinase activity (GO:0043406) | 0.000803592260076488 |
| substrate-specific transporter activity (GO:0022892) | 0.00080487576393885 |
| phospholipid biosynthetic process (GO:0008654) | 0.000821852459088434 |
| sterol transport (GO:0015918) | 0.000825898115989464 |
| axis specification (GO:0009798) | 0.000825898115989464 |
| receptor signaling complex scaffold activity (GO:0030159) | 0.000825898115989464 |
| synaptic vesicle transport (GO:0048489) | 0.000825898115989464 |
| cholesterol transport (GO:0030301) | 0.000825898115989464 |
| microvillus (GO:0005902) | 0.000825898115989464 |
| branching morphogenesis of a tube (GO:0048754) | 0.000835346014994474 |
| vacuolar membrane (GO:0005774) | 0.000835346014994474 |
| chromatin remodeling (GO:0006338) | 0.000835346014994474 |
| excretion (GO:0007588) | 0.000835346014994474 |
| mesoderm formation (GO:0001707) | 0.000835346014994474 |
| glycolipid biosynthetic process (GO:0009247) | 0.000835346014994474 |
| gland development (GO:0048732) | 0.000879512370938154 |
| cell projection biogenesis (GO:0030031) | 0.000896349114471979 |
| Ras protein signal transduction (GO:0007265) | 0.000973956476602263 |
| male sex differentiation (GO:0046661) | 0.000990647236705673 |
| insulin receptor signaling pathway (GO:0008286) | 0.000990647236705673 |
| response to metal ion (GO:0010038) | 0.00108514406844021 |
| histone methyltransferase activity (GO:0042054) | 0.00108514406844021 |
| Rho protein signal transduction (GO:0007266) | 0.00109365966524591 |
| protein targeting (GO:0006605) | 0.0010986992720814 |
| actin filament binding (GO:0051015) | 0.00121044943302189 |
| negative regulation of transferase activity (GO:0051348) | 0.00122695628954989 |
| endocytic vesicle (GO:0030139) | 0.00124655336608392 |
| late endosome membrane (GO:0031902) | 0.00127047468872645 |
| glial cell differentiation (GO:0010001) | 0.00127047468872645 |
| small GTPase regulator activity (GO:0005083) | 0.00127806522435852 |
| ruffle (GO:0001726) | 0.00127806522435852 |
| lysosomal membrane (GO:0005765) | 0.00130452113950784 |
| steroid binding (GO:0005496) | 0.00130555680756389 |
| recycling endosome (GO:0055037) | 0.00132028158690874 |
| glycosphingolipid biosynthetic process (GO:0006688) | 0.00132028158690874 |
| response to abiotic stimulus (GO:0009628) | 0.001410605916498 |
| oxidoreductase activity, acting on CH-OH group of donors (GO:0016614) | 0.001410605916498 |
| glycosphingolipid metabolic process (GO:0006687) | 0.00143634972166272 |
| regulation of transforming growth factor beta receptor signaling pathway (GO:0017015) | 0.00143634972166272 |
| actin filament bundle formation (GO:0051017) | 0.00143634972166272 |
| positive regulation of developmental process (GO:0051094) | 0.0014569194857713 |
| kinase activity (GO:0016301) | 0.00149987508973485 |
| vacuolar part (GO:0044437) | 0.00156993072917708 |
| cell cortex (GO:0005938) | 0.00156993072917708 |
| positive regulation of neurogenesis (GO:0050769) | 0.00156993072917708 |
| regulation of systemic arterial blood pressure (GO:0003073) | 0.00156993072917708 |
| focal adhesion formation (GO:0048041) | 0.00156993072917708 |
| positive regulation of axonogenesis (GO:0050772) | 0.00156993072917708 |
| development of primary male sexual characteristics (GO:0046546) | 0.00158239739393363 |
| polysaccharide metabolic process (GO:0005976) | 0.00166922889880432 |
| kidney development (GO:0001822) | 0.00171412337322769 |
| microtubule-based process (GO:0007017) | 0.00178565438579027 |
| cell-cell adhesion (GO:0016337) | 0.00181086378580071 |
| reproductive structure development (GO:0048608) | 0.00184482946695846 |
| gonad development (GO:0008406) | 0.00184482946695846 |
| acetylgalactosaminyltransferase activity (GO:0008376) | 0.00184976229485779 |
| regulation of epithelial cell proliferation (GO:0050678) | 0.00184976229485779 |
| glucose transport (GO:0015758) | 0.00184976229485779 |
| cellular lipid catabolic process (GO:0044242) | 0.00188081695965912 |
| histone deacetylase complex (GO:0000118) | 0.00196343528498288 |
| glycoprotein biosynthetic process (GO:0009101) | 0.00198084540785319 |
| amino acid catabolic process (GO:0009063) | 0.00213641239621273 |
| glycosaminoglycan binding (GO:0005539) | 0.00217852916613461 |
| amino acid metabolic process (GO:0006520) | 0.00222073034949206 |
| apical protein localization (GO:0045176) | 0.00223286333819144 |
| lateral plasma membrane (GO:0016328) | 0.00223286333819144 |
| synaptic vesicle exocytosis (GO:0016079) | 0.00223286333819144 |
| passive transmembrane transporter activity (GO:0022803) | 0.00223286333819144 |
| channel activity (GO:0015267) | 0.00223286333819144 |
| glycoprotein metabolic process (GO:0009100) | 0.00223341925601881 |
| integral to Golgi membrane (GO:0030173) | 0.00226526798395602 |
| biogenic amine metabolic process (GO:0006576) | 0.00229768194583065 |
| mitosis (GO:0007067) | 0.00232661993983355 |
| PDZ domain binding (GO:0030165) | 0.00235596791392863 |
| sterol binding (GO:0032934) | 0.00235828998261369 |
| myoblast differentiation (GO:0045445) | 0.00235828998261369 |
| glutamine family amino acid metabolic process (GO:0009064) | 0.00237013545578478 |
| negative regulation of kinase activity (GO:0033673) | 0.0024111423764985 |
| negative regulation of protein kinase activity (GO:0006469) | 0.0024111423764985 |
| neurological system process (GO:0050877) | 0.00251880073342071 |
| limb development (GO:0060173) | 0.00260983271618397 |
| response to steroid hormone stimulus (GO:0048545) | 0.00260983271618397 |
| appendage development (GO:0048736) | 0.00260983271618397 |
| appendage morphogenesis (GO:0035107) | 0.00260983271618397 |
| limb morphogenesis (GO:0035108) | 0.00260983271618397 |
| regulation of membrane potential (GO:0042391) | 0.00263345128697548 |
| ossification (GO:0001503) | 0.00265623854967138 |
| biomineral formation (GO:0031214) | 0.00265623854967138 |
| chromatin remodeling complex (GO:0016585) | 0.00269273341482324 |
| cilium (GO:0005929) | 0.00269273341482324 |
| UDP-galactosyltransferase activity (GO:0035250) | 0.00270356194738467 |
| learning (GO:0007612) | 0.00270356194738467 |
| lipid homeostasis (GO:0055088) | 0.00270356194738467 |
| dopamine metabolic process (GO:0042417) | 0.00288083506380339 |
| striated muscle thin filament (GO:0005865) | 0.00288083506380339 |
| guanylate kinase activity (GO:0004385) | 0.00288083506380339 |
| patterning of blood vessels (GO:0001569) | 0.00288083506380339 |
| adult locomotory behavior (GO:0008344) | 0.00293928040956651 |
| neural crest cell differentiation (GO:0014033) | 0.00293928040956651 |
| neural crest cell development (GO:0014032) | 0.00293928040956651 |
| nucleotide-sugar metabolic process (GO:0009225) | 0.00293928040956651 |
| transferase activity, transferring phosphorus-containing groups (GO:0016772) | 0.00293928040956651 |
| mesenchymal cell development (GO:0014031) | 0.00293928040956651 |
| mesenchymal cell differentiation (GO:0048762) | 0.00293928040956651 |
| amine transport (GO:0015837) | 0.00296048256361576 |
| cellular polysaccharide metabolic process (GO:0044264) | 0.00296048256361576 |
| transferase activity, transferring sulfur-containing groups (GO:0016782) | 0.00297520237809076 |
| acid-amino acid ligase activity (GO:0016881) | 0.00302279392259174 |
| lipid catabolic process (GO:0016042) | 0.0033674185979357 |
| ephrin receptor activity (GO:0005003) | 0.00338658179197789 |
| regulation of protein transport (GO:0051223) | 0.00338658179197789 |
| regulation of heart rate (GO:0002027) | 0.00338658179197789 |
| cytochrome-b5 reductase activity (GO:0004128) | 0.00338658179197789 |
| dendritic spine (GO:0043197) | 0.00338658179197789 |
| enoyl-CoA hydratase activity (GO:0004300) | 0.00338658179197789 |
| 3-hydroxyacyl-CoA dehydrogenase activity (GO:0003857) | 0.00338658179197789 |
| ephrin receptor binding (GO:0046875) | 0.00338658179197789 |
| protein deubiquitination (GO:0016579) | 0.00338658179197789 |
| neuromuscular junction (GO:0031594) | 0.00338658179197789 |
| stereocilium (GO:0032420) | 0.00338658179197789 |
| stereocilium bundle (GO:0032421) | 0.00338658179197789 |
| protein import (GO:0017038) | 0.00344074048256725 |
| extrinsic to plasma membrane (GO:0019897) | 0.00359190759001997 |
| regulation of biosynthetic process (GO:0009889) | 0.00359190759001997 |
| phospholipid transporter activity (GO:0005548) | 0.00359190759001997 |
| ensheathment of neurons (GO:0007272) | 0.00359190759001997 |
| axon ensheathment (GO:0008366) | 0.00359190759001997 |
| hexose transport (GO:0008645) | 0.00359190759001997 |
| ceramide metabolic process (GO:0006672) | 0.00359190759001997 |
| monosaccharide transport (GO:0015749) | 0.00359190759001997 |
| AMP binding (GO:0016208) | 0.00359190759001997 |
| aminoglycan biosynthetic process (GO:0006023) | 0.00359190759001997 |
| post-Golgi vesicle-mediated transport (GO:0006892) | 0.00359190759001997 |
| mRNA binding (GO:0003729) | 0.00363304710186399 |
| lipid raft (GO:0045121) | 0.00373704645403245 |
| glycerophospholipid biosynthetic process (GO:0046474) | 0.00373704645403245 |
| positive regulation of transport (GO:0051050) | 0.00378057823288292 |
| cell-substrate adherens junction (GO:0005924) | 0.00378057823288292 |
| regulation of cell morphogenesis (GO:0022604) | 0.00378758508872073 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 0.00378758508872073 |
| regulation of cell shape (GO:0008360) | 0.00378758508872073 |
| response to inorganic substance (GO:0010035) | 0.00378758508872073 |
| nitrogen compound biosynthetic process (GO:0044271) | 0.00383776616846168 |
| biopolymer glycosylation (GO:0043413) | 0.00392015069303484 |
| oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen (GO:0016705) | 0.00392015069303484 |
| metal ion homeostasis (GO:0055065) | 0.00403784524063702 |
| cellular metal ion homeostasis (GO:0006875) | 0.00403784524063702 |
| protein lipoylation (GO:0009249) | 0.00403784524063702 |
| N-acetyllactosamine synthase activity (GO:0003945) | 0.00403784524063702 |
| activin receptor activity, type I (GO:0016361) | 0.00403784524063702 |
| receptor tyrosine kinase binding (GO:0030971) | 0.00403784524063702 |
| actin filament severing (GO:0051014) | 0.00403784524063702 |
| beta-catenin destruction complex (GO:0030877) | 0.00403784524063702 |
| oxidoreductase activity, acting on sulfur group of donors, oxygen as acceptor (GO:0016670) | 0.00403784524063702 |
| chromatin-mediated maintenance of transcription (GO:0048096) | 0.00403784524063702 |
| actin monomer binding (GO:0003785) | 0.00403784524063702 |
| carnitine O-palmitoyltransferase activity (GO:0004095) | 0.00403784524063702 |
| nucleoside triphosphate catabolic process (GO:0009143) | 0.00403784524063702 |
| costamere (GO:0043034) | 0.00403784524063702 |
| O-palmitoyltransferase activity (GO:0016416) | 0.00403784524063702 |
| non-membrane-bound organelle (GO:0043228) | 0.00413047744245749 |
| intracellular non-membrane-bound organelle (GO:0043232) | 0.00413047744245749 |
| cholesterol biosynthetic process (GO:0006695) | 0.00417966605437922 |
| actin filament (GO:0005884) | 0.00417966605437922 |
| regulation of catabolic process (GO:0009894) | 0.00417966605437922 |
| cyclic nucleotide binding (GO:0030551) | 0.00417966605437922 |
| enzyme activator activity (GO:0008047) | 0.00418853642364742 |
| neuromuscular process controlling balance (GO:0050885) | 0.0042234317093864 |
| positive regulation of epithelial cell proliferation (GO:0050679) | 0.0042234317093864 |
| transforming growth factor beta receptor activity (GO:0005024) | 0.0042234317093864 |
| transmembrane receptor protein serine/threonine kinase activity (GO:0004675) | 0.0042234317093864 |
| polypeptide N-acetylgalactosaminyltransferase activity (GO:0004653) | 0.0042234317093864 |
| extracellular space (GO:0005615) | 0.00436346754953452 |
| ion channel activity (GO:0005216) | 0.00441050995250845 |
| S-adenosylmethionine-dependent methyltransferase activity (GO:0008757) | 0.00446150682373733 |
| M phase of mitotic cell cycle (GO:0000087) | 0.00446173078540945 |
| regulation of nucleocytoplasmic transport (GO:0046822) | 0.00457460625736444 |
| mRNA catabolic process (GO:0006402) | 0.00457460625736444 |
| peroxisome organization and biogenesis (GO:0007031) | 0.00457460625736444 |
| proteoglycan metabolic process (GO:0006029) | 0.00457460625736444 |
| macromolecule catabolic process (GO:0009057) | 0.00467765047379576 |
| cholesterol homeostasis (GO:0042632) | 0.00491743786170051 |
| sterol homeostasis (GO:0055092) | 0.00491743786170051 |
| establishment and/or maintenance of apical/basal cell polarity (GO:0035088) | 0.00496738298314868 |
| heart looping (GO:0001947) | 0.00496738298314868 |
| anchoring collagen (GO:0030934) | 0.00496738298314868 |
| protein homotetramerization (GO:0051289) | 0.00496738298314868 |
| histone methylation (GO:0016571) | 0.00496738298314868 |
| male genitalia development (GO:0030539) | 0.00496738298314868 |
| filopodium (GO:0030175) | 0.00496738298314868 |
| beta-catenin binding (GO:0008013) | 0.00496738298314868 |
| sphingoid biosynthetic process (GO:0046520) | 0.00496738298314868 |
| protein amino acid glycosylation (GO:0006486) | 0.00506222626773112 |
| phospholipid metabolic process (GO:0006644) | 0.00511427822770811 |
| bone remodeling (GO:0046849) | 0.00517087028773174 |
| morphogenesis of embryonic epithelium (GO:0016331) | 0.00524139759845864 |
| two-component signal transduction system (phosphorelay) (GO:0000160) | 0.00524139759845864 |
| L-ascorbic acid binding (GO:0031418) | 0.00524139759845864 |
| response to peptide hormone stimulus (GO:0043434) | 0.00524139759845864 |
| phosphorylation (GO:0016310) | 0.00524794988226743 |
| regulation of calcium ion transport (GO:0051924) | 0.00524794988226743 |
| positive regulation of angiogenesis (GO:0045766) | 0.00524794988226743 |
| regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 0.00524794988226743 |
| anion binding (GO:0043168) | 0.00535268786846459 |
| chloride ion binding (GO:0031404) | 0.00535268786846459 |
| response to nutrient levels (GO:0031667) | 0.00535268786846459 |
| regulation of phosphorus metabolic process (GO:0051174) | 0.00564656169888422 |
| regulation of phosphate metabolic process (GO:0019220) | 0.00564656169888422 |
| neurotransmitter transport (GO:0006836) | 0.00564656169888422 |
| ligase activity, forming carbon-nitrogen bonds (GO:0016879) | 0.00576666782274734 |
| M phase (GO:0000279) | 0.00580289763952281 |
| Ras guanyl-nucleotide exchange factor activity (GO:0005088) | 0.00585523597056766 |
| myelination (GO:0042552) | 0.00591122878889296 |
| polysaccharide binding (GO:0030247) | 0.00621460947764188 |
| protein serine/threonine phosphatase activity (GO:0004722) | 0.00632239591355876 |
| negative regulation of cell differentiation (GO:0045596) | 0.00632239591355876 |
| site of polarized growth (GO:0030427) | 0.00655880827439931 |
| glutathione metabolic process (GO:0006749) | 0.00655880827439931 |
| synapse part (GO:0044456) | 0.00680892472123207 |
| substrate specific channel activity (GO:0022838) | 0.00717021634151468 |
| activation of protein kinase activity (GO:0032147) | 0.00725744988235061 |
| peptidyl-tyrosine modification (GO:0018212) | 0.00730745872924847 |
| protein kinase inhibitor activity (GO:0004860) | 0.0076223089944789 |
| cell-matrix junction (GO:0030055) | 0.0076223089944789 |
| hindbrain development (GO:0030902) | 0.00774709932439963 |
| cartilage development (GO:0051216) | 0.00774709932439963 |
| activation of MAPK activity (GO:0000187) | 0.00780710210549055 |
| vesicle organization and biogenesis (GO:0016050) | 0.0080587556515474 |
| vasoconstriction (GO:0042310) | 0.0080587556515474 |
| growth factor binding (GO:0019838) | 0.0083246005419961 |
| inner ear morphogenesis (GO:0042472) | 0.00839263540153354 |
| transmembrane transporter activity (GO:0022857) | 0.00871425697930995 |
| nitric-oxide synthase binding (GO:0050998) | 0.00886953568398184 |
| positive regulation of gene expression, epigenetic (GO:0045815) | 0.00886953568398184 |
| neurofilament (GO:0005883) | 0.00886953568398184 |
| determination of anterior/posterior axis, embryo (GO:0008595) | 0.00886953568398184 |
| arginine catabolic process (GO:0006527) | 0.00886953568398184 |
| Golgi to plasma membrane transport (GO:0006893) | 0.00886953568398184 |
| establishment of tissue polarity (GO:0007164) | 0.00886953568398184 |
| neurofilament cytoskeleton (GO:0060053) | 0.00886953568398184 |
| tripartite regional subdivision (GO:0007351) | 0.00886953568398184 |
| blastoderm segmentation (GO:0007350) | 0.00886953568398184 |
| embryonic axis specification (GO:0000578) | 0.00886953568398184 |
| ventricular cardiac muscle morphogenesis (GO:0055010) | 0.00886953568398184 |
| response to organic substance (GO:0010033) | 0.00906647658408041 |
| small conjugating protein ligase activity (GO:0019787) | 0.00906647658408041 |
| delayed rectifier potassium channel activity (GO:0005251) | 0.00931786893808525 |
| clathrin coat of coated pit (GO:0030132) | 0.00931786893808525 |
| camera-type eye morphogenesis (GO:0048593) | 0.00931786893808525 |
| plasma membrane organization and biogenesis (GO:0007009) | 0.00931786893808525 |
| regulation of smooth muscle contraction (GO:0006940) | 0.00985405701095641 |
| glutamine family amino acid catabolic process (GO:0009065) | 0.00985405701095641 |
| sperm motility (GO:0030317) | 0.00985405701095641 |
| glycosaminoglycan biosynthetic process (GO:0006024) | 0.00985405701095641 |
| SH3 domain binding (GO:0017124) | 0.00985405701095641 |
| biopolymer methylation (GO:0043414) | 0.00987962482827879 |
| desmosome (GO:0030057) | 0.00987962482827879 |
| filamentous actin (GO:0031941) | 0.00987962482827879 |
| phosphoprotein binding (GO:0051219) | 0.00987962482827879 |
| neuron maturation (GO:0042551) | 0.00987962482827879 |
| peptidyl-serine phosphorylation (GO:0018105) | 0.00987962482827879 |
| channel inhibitor activity (GO:0016248) | 0.00987962482827879 |
| intramolecular oxidoreductase activity, interconverting keto- and enol-groups (GO:0016862) | 0.00987962482827879 |
| asymmetric protein localization (GO:0008105) | 0.00987962482827879 |
| ion channel inhibitor activity (GO:0008200) | 0.00987962482827879 |
| peptidyl-serine modification (GO:0018209) | 0.00987962482827879 |
| cellular cation homeostasis (GO:0030003) | 0.0100254649681148 |
| electron carrier activity (GO:0009055) | 0.0103531678060857 |
| regulation of adenylate cyclase activity (GO:0045761) | 0.0104561985558569 |
| I-kappaB kinase/NF-kappaB cascade (GO:0007249) | 0.0104676899718787 |
| dephosphorylation (GO:0016311) | 0.0105437086603988 |
| negative regulation of MAP kinase activity (GO:0043407) | 0.0108591604553073 |
| hexose biosynthetic process (GO:0019319) | 0.0108632879930897 |
| G-protein signaling, adenylate cyclase activating pathway (GO:0007189) | 0.0108632879930897 |
| embryonic limb morphogenesis (GO:0030326) | 0.0109931068279377 |
| nuclear DNA-directed RNA polymerase complex (GO:0055029) | 0.0109931068279377 |
| embryonic appendage morphogenesis (GO:0035113) | 0.0109931068279377 |
| DNA-directed RNA polymerase complex (GO:0000428) | 0.0109931068279377 |
| transcription from RNA polymerase III promoter (GO:0006383) | 0.0112183671495625 |
| regulation of lipid metabolic process (GO:0019216) | 0.0112183671495625 |
| regulation of binding (GO:0051098) | 0.0112183671495625 |
| microtubule polymerization or depolymerization (GO:0031109) | 0.0112183671495625 |
| L-amino acid transmembrane transporter activity (GO:0015179) | 0.0112183671495625 |
| phosphotransferase activity, nitrogenous group as acceptor (GO:0016775) | 0.0112183671495625 |
| interspecies interaction between organisms (GO:0044419) | 0.0112183671495625 |
| symbiosis, encompassing mutualism through parasitism (GO:0044403) | 0.0112183671495625 |
| response to drug (GO:0042493) | 0.0113208931352921 |
| dopamine receptor signaling pathway (GO:0007212) | 0.0122808627936299 |
| embryonic epithelial tube formation (GO:0001838) | 0.0122808627936299 |
| protein import into nucleus (GO:0006606) | 0.0125005826416283 |
| RNA catabolic process (GO:0006401) | 0.0132666961323299 |
| extracellular matrix organization and biogenesis (GO:0030198) | 0.0132666961323299 |
| cellular calcium ion homeostasis (GO:0006874) | 0.013830137923199 |
| calcium ion homeostasis (GO:0055074) | 0.013830137923199 |
| cation homeostasis (GO:0055080) | 0.0142101582475601 |
| phosphoric monoester hydrolase activity (GO:0016791) | 0.0142101582475601 |
| regulation of transcription factor import into nucleus (GO:0042990) | 0.0142101582475601 |
| transcription factor import into nucleus (GO:0042991) | 0.0142101582475601 |
| calmodulin-dependent protein kinase activity (GO:0004683) | 0.0142101582475601 |
| regulation of lyase activity (GO:0051339) | 0.0142772677897618 |
| regulation of cyclase activity (GO:0031279) | 0.0142772677897618 |
| kinase inhibitor activity (GO:0019210) | 0.0142772677897618 |
| intracellular receptor-mediated signaling pathway (GO:0030522) | 0.0142994082108446 |
| regulation of blood pressure (GO:0008217) | 0.0142994082108446 |
| response to endogenous stimulus (GO:0009719) | 0.0145303681426927 |
| receptor binding (GO:0005102) | 0.0145473117745135 |
| cell proliferation in hindbrain (GO:0021534) | 0.0145473117745135 |
| perikaryon (GO:0043204) | 0.0145473117745135 |
| translation activator activity (GO:0008494) | 0.0145473117745135 |
| epithelial cell development (GO:0002064) | 0.0145473117745135 |
| basal body (GO:0005932) | 0.0145473117745135 |
| cell proliferation in the external granule layer (GO:0021924) | 0.0145473117745135 |
| positive regulation of granule cell precursor proliferation (GO:0021940) | 0.0145473117745135 |
| Wnt receptor signaling pathway through beta-catenin (GO:0060070) | 0.0145473117745135 |
| regulation of activin receptor signaling pathway (GO:0032925) | 0.0145473117745135 |
| intermediate filament organization (GO:0045109) | 0.0145473117745135 |
| intrinsic to mitochondrial outer membrane (GO:0031306) | 0.0145473117745135 |
| embryonic hindlimb morphogenesis (GO:0035116) | 0.0145473117745135 |
| regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993) | 0.0145473117745135 |
| regulation of granule cell precursor proliferation (GO:0021936) | 0.0145473117745135 |
| dorsal/ventral axis specification (GO:0009950) | 0.0145473117745135 |
| neurofilament cytoskeleton organization and biogenesis (GO:0060052) | 0.0145473117745135 |
| activin receptor signaling pathway (GO:0032924) | 0.0145473117745135 |
| granule cell precursor proliferation (GO:0021930) | 0.0145473117745135 |
| neuronal ion channel clustering (GO:0045161) | 0.0145473117745135 |
| associative learning (GO:0008306) | 0.0145473117745135 |
| GTP-Rho binding (GO:0017049) | 0.0145473117745135 |
| histone-arginine N-methyltransferase activity (GO:0008469) | 0.0145473117745135 |
| T-tubule (GO:0030315) | 0.0145473117745135 |
| GTPase binding (GO:0051020) | 0.0146105652099785 |
| odontogenesis (GO:0042476) | 0.014624309495791 |
| thyroid hormone receptor binding (GO:0046966) | 0.014624309495791 |
| regulation of intracellular transport (GO:0032386) | 0.014624309495791 |
| nucleotide catabolic process (GO:0009166) | 0.014624309495791 |
| positive regulation of cellular component organization and biogenesis (GO:0051130) | 0.014624309495791 |
| specific transcriptional repressor activity (GO:0016566) | 0.014624309495791 |
| cell adhesion molecule binding (GO:0050839) | 0.014624309495791 |
| intermediate filament cytoskeleton organization and biogenesis (GO:0045104) | 0.014624309495791 |
| mammary gland development (GO:0030879) | 0.014624309495791 |
| anchored to plasma membrane (GO:0046658) | 0.014624309495791 |
| amino acid derivative catabolic process (GO:0042219) | 0.014624309495791 |
| monosaccharide biosynthetic process (GO:0046364) | 0.014624309495791 |
| protein kinase C activation (GO:0007205) | 0.014624309495791 |
| alcohol biosynthetic process (GO:0046165) | 0.014624309495791 |
| female sex differentiation (GO:0046660) | 0.0146303412654111 |
| development of primary female sexual characteristics (GO:0046545) | 0.0146303412654111 |
| response to temperature stimulus (GO:0009266) | 0.0146303412654111 |
| regulation of endocytosis (GO:0030100) | 0.0151738269792589 |
| focal adhesion (GO:0005925) | 0.0151738269792589 |
| G1/S transition of mitotic cell cycle (GO:0000082) | 0.0151738269792589 |
| hormone secretion (GO:0046879) | 0.0151738269792589 |
| RNA polymerase complex (GO:0030880) | 0.0151738269792589 |
| steroid hormone receptor signaling pathway (GO:0030518) | 0.0152937526473437 |
| protein catabolic process (GO:0030163) | 0.015513672014972 |
| calcium channel regulator activity (GO:0005246) | 0.0171941540974133 |
| vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 0.0171941540974133 |
| nuclear import (GO:0051170) | 0.0172260184127569 |
| inactivation of MAPK activity (GO:0000188) | 0.0177894584155706 |
| kinase activator activity (GO:0019209) | 0.0177894584155706 |
| growth cone (GO:0030426) | 0.0177894584155706 |
| BMP signaling pathway (GO:0030509) | 0.0177894584155706 |
| potassium channel regulator activity (GO:0015459) | 0.0177894584155706 |
| neurotransmitter uptake (GO:0001504) | 0.0178431414147859 |
| equilibrioception (GO:0050957) | 0.0178431414147859 |
| neurotransmitter catabolic process (GO:0042135) | 0.0178431414147859 |
| ceramide biosynthetic process (GO:0046513) | 0.0178431414147859 |
| muscle morphogenesis (GO:0048644) | 0.0178431414147859 |
| amide metabolic process (GO:0043603) | 0.0178431414147859 |
| protein heterooligomerization (GO:0051291) | 0.0178431414147859 |
| cardiac muscle morphogensis (GO:0055008) | 0.0178431414147859 |
| urea cycle (GO:0000050) | 0.0178431414147859 |
| SWI/SNF complex (GO:0016514) | 0.0178431414147859 |
| response to alkaloid (GO:0043279) | 0.0178431414147859 |
| urea metabolic process (GO:0019627) | 0.0178431414147859 |
| regulation of fatty acid metabolic process (GO:0019217) | 0.0178431414147859 |
| sodium:potassium-exchanging ATPase complex (GO:0005890) | 0.0178431414147859 |
| endosome organization and biogenesis (GO:0007032) | 0.0178431414147859 |
| adult walking behavior (GO:0007628) | 0.0178431414147859 |
| organelle fission (GO:0048285) | 0.0178431414147859 |
| ganglioside metabolic process (GO:0001573) | 0.0178431414147859 |
| CDP-alcohol phosphatidyltransferase activity (GO:0017169) | 0.0178431414147859 |
| regulation of systemic arterial blood pressure by neurological process (GO:0001976) | 0.0178431414147859 |
| mitochondrion organization and biogenesis (GO:0007005) | 0.0190288650518355 |
| nitric oxide metabolic process (GO:0046209) | 0.0190288650518355 |
| nitric oxide biosynthetic process (GO:0006809) | 0.0190288650518355 |
| oligosaccharide metabolic process (GO:0009311) | 0.0190288650518355 |
| regulation of intracellular protein transport (GO:0033157) | 0.0190288650518355 |
| regulation of protein import into nucleus (GO:0042306) | 0.0190288650518355 |
| calcium-independent cell-cell adhesion (GO:0016338) | 0.0190288650518355 |
| steroid hormone receptor binding (GO:0035258) | 0.0191363067089798 |
| regulation of neuron differentiation (GO:0045664) | 0.0194454406046281 |
| catecholamine metabolic process (GO:0006584) | 0.0194454406046281 |
| sulfotransferase activity (GO:0008146) | 0.0195882116893963 |
| smooth muscle contraction (GO:0006939) | 0.0197526603269941 |
| Golgi to plasma membrane protein transport (GO:0043001) | 0.0197829145546719 |
| atypical protein kinase C activity (GO:0004700) | 0.0197829145546719 |
| purine ribonucleoside triphosphate catabolic process (GO:0009207) | 0.0197829145546719 |
| glutamate catabolic process (GO:0006538) | 0.0197829145546719 |
| L-ascorbic acid metabolic process (GO:0019852) | 0.0197829145546719 |
| negative regulation of myoblast differentiation (GO:0045662) | 0.0197829145546719 |
| axon guidance receptor activity (GO:0008046) | 0.0197829145546719 |
| regulation of odontogenesis of dentine-containing teeth (GO:0042487) | 0.0197829145546719 |
| axon regeneration (GO:0031103) | 0.0197829145546719 |
| response to tropane (GO:0014073) | 0.0197829145546719 |
| glycerol-3-phosphate dehydrogenase activity (GO:0004368) | 0.0197829145546719 |
| protein kinase C inhibitor activity (GO:0008426) | 0.0197829145546719 |
| positive regulation of activin receptor signaling pathway (GO:0032927) | 0.0197829145546719 |
| phosphatidate cytidylyltransferase activity (GO:0004605) | 0.0197829145546719 |
| negative regulation of axon extension (GO:0030517) | 0.0197829145546719 |
| ribonucleoside triphosphate catabolic process (GO:0009203) | 0.0197829145546719 |
| beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity (GO:0003831) | 0.0197829145546719 |
| ATP catabolic process (GO:0006200) | 0.0197829145546719 |
| peptidyl-arginine methylation (GO:0018216) | 0.0197829145546719 |
| purine nucleoside triphosphate catabolic process (GO:0009146) | 0.0197829145546719 |
| pyrimidine nucleotide catabolic process (GO:0006244) | 0.0197829145546719 |
| wound healing, spreading of epidermal cells (GO:0035313) | 0.0197829145546719 |
| phosphatidic acid biosynthetic process (GO:0006654) | 0.0197829145546719 |
| citrate metabolic process (GO:0006101) | 0.0197829145546719 |
| peptidyl-threonine phosphorylation (GO:0018107) | 0.0197829145546719 |
| nicotinamide-nucleotide adenylyltransferase activity (GO:0000309) | 0.0197829145546719 |
| mitochondrial crista (GO:0030061) | 0.0197829145546719 |
| positive regulation of heart rate (GO:0010460) | 0.0197829145546719 |
| peptidyl-threonine modification (GO:0018210) | 0.0197829145546719 |
| epidermal growth factor receptor activity (GO:0005006) | 0.0197829145546719 |
| establishment of apical/basal cell polarity (GO:0035089) | 0.0197829145546719 |
| neurite regeneration (GO:0031102) | 0.0197829145546719 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase activity (GO:0003865) | 0.0197829145546719 |
| response to cocaine (GO:0042220) | 0.0197829145546719 |
| phosphoinositide-mediated signaling (GO:0048015) | 0.0199800980510818 |
| O-acyltransferase activity (GO:0008374) | 0.0204792132647279 |
| response to extracellular stimulus (GO:0009991) | 0.0208655792716943 |
| histone modification (GO:0016570) | 0.0213311650108488 |
| interphase of mitotic cell cycle (GO:0051329) | 0.0214192938571062 |
| protein secretion (GO:0009306) | 0.0216312263635771 |
| sodium channel activity (GO:0005272) | 0.0216312263635771 |
| mechanoreceptor differentiation (GO:0042490) | 0.0216779784338549 |
| phorbol ester receptor activity (GO:0001565) | 0.0216779784338549 |
| protein kinase C activity (GO:0004697) | 0.0216779784338549 |
| anchored to membrane (GO:0031225) | 0.0216779784338549 |
| adrenoceptor activity (GO:0004935) | 0.0216779784338549 |
| intermediate filament-based process (GO:0045103) | 0.0216779784338549 |
| non-G-protein coupled 7TM receptor activity (GO:0004926) | 0.0216779784338549 |
| inner ear receptor cell differentiation (GO:0060113) | 0.0216779784338549 |
| cell surface receptor linked signal transduction (GO:0007166) | 0.0217269508143256 |
| hydro-lyase activity (GO:0016836) | 0.0219053466160725 |
| interphase (GO:0051325) | 0.0219053466160725 |
| ion transmembrane transporter activity (GO:0015075) | 0.0241650935565527 |
| odontogenesis of dentine-containing teeth (GO:0042475) | 0.0244926546027558 |
| neural tube development (GO:0021915) | 0.0244926546027558 |
| negative regulation of cell migration (GO:0030336) | 0.0244926546027558 |
| male gonad development (GO:0008584) | 0.0244926546027558 |
| collagen binding (GO:0005518) | 0.0244926546027558 |
| female pregnancy (GO:0007565) | 0.0246590335102411 |
| phenol metabolic process (GO:0018958) | 0.0251232913251593 |
| protein-lysine N-methyltransferase activity (GO:0016279) | 0.0251232913251593 |
| RNA polymerase II transcription factor activity, enhancer binding (GO:0003705) | 0.0251232913251593 |
| histone-lysine N-methyltransferase activity (GO:0018024) | 0.0251232913251593 |
| lysine N-methyltransferase activity (GO:0016278) | 0.0251232913251593 |
| negative regulation of cell motility (GO:0051271) | 0.0253259075163819 |
| zinc ion transport (GO:0006829) | 0.0253259075163819 |
| brush border (GO:0005903) | 0.0253259075163819 |
| phosphoric ester hydrolase activity (GO:0042578) | 0.0253272081195576 |
| vitamin metabolic process (GO:0006766) | 0.025350616112394 |
| di-, tri-valent inorganic cation transport (GO:0015674) | 0.025350616112394 |
| protein amino acid dephosphorylation (GO:0006470) | 0.025350616112394 |
| amine receptor activity (GO:0008227) | 0.0254624141192107 |
| endosome transport (GO:0016197) | 0.0256469776038519 |
| regulation of cellular biosynthetic process (GO:0031326) | 0.0264969170354147 |
| negative regulation of neurogenesis (GO:0050768) | 0.0266922462442334 |
| synaptic transmission, cholinergic (GO:0007271) | 0.0266922462442334 |
| palmitoyltransferase activity (GO:0016409) | 0.0266922462442334 |
| neural tube closure (GO:0001843) | 0.0266922462442334 |
| positive regulation of multicellular organism growth (GO:0040018) | 0.0266922462442334 |
| behavioral interaction between organisms (GO:0051705) | 0.0266922462442334 |
| primary neural tube formation (GO:0014020) | 0.0266922462442334 |
| protein kinase activator activity (GO:0030295) | 0.0266922462442334 |
| RNA-mediated gene silencing (GO:0031047) | 0.0266922462442334 |
| presynaptic membrane (GO:0042734) | 0.0266922462442334 |
| regulation of anti-apoptosis (GO:0045767) | 0.0266922462442334 |
| C-acyltransferase activity (GO:0016408) | 0.0266922462442334 |
| mating (GO:0007618) | 0.0266922462442334 |
| tissue morphogenesis (GO:0048729) | 0.0268240945185313 |
| biosynthetic process (GO:0009058) | 0.0270403384418367 |
| transferase activity, transferring hexosyl groups (GO:0016758) | 0.0280258607198794 |
| substrate-specific transmembrane transporter activity (GO:0022891) | 0.0292026754490685 |
| pattern binding (GO:0001871) | 0.0302693383739796 |
| negative regulation of cell size (GO:0045792) | 0.0305846223526549 |
| collagen (GO:0005581) | 0.0305846223526549 |
| di-, tri-valent inorganic cation transmembrane transporter activity (GO:0015082) | 0.0305846223526549 |
| tricarboxylic acid cycle intermediate metabolic process (GO:0006100) | 0.0307957968205603 |
| microtubule cytoskeleton organization and biogenesis (GO:0000226) | 0.0311555043072229 |
| epidermal growth factor receptor binding (GO:0005154) | 0.0314898732031168 |
| protein import into peroxisome matrix (GO:0016558) | 0.0314898732031168 |
| ATP-binding cassette (ABC) transporter complex (GO:0043190) | 0.0314898732031168 |
| protein disulfide isomerase activity (GO:0003756) | 0.0314898732031168 |
| intramolecular oxidoreductase activity, transposing S-S bonds (GO:0016864) | 0.0314898732031168 |
| alpha-adrenergic receptor activity (GO:0004936) | 0.0314898732031168 |
| substrate-bound cell migration (GO:0006929) | 0.0314898732031168 |
| peptidyl-arginine modification (GO:0018195) | 0.0314898732031168 |
| retinoic acid receptor binding (GO:0042974) | 0.0314898732031168 |
| mRNA polyadenylation (GO:0006378) | 0.0314898732031168 |
| neural plate morphogenesis (GO:0001839) | 0.0315192574589152 |
| glutamate metabolic process (GO:0006536) | 0.0315192574589152 |
| pigmentation during development (GO:0048066) | 0.0315192574589152 |
| SMAD binding (GO:0046332) | 0.0315192574589152 |
| basal part of cell (GO:0045178) | 0.0315192574589152 |
| basal plasma membrane (GO:0009925) | 0.0315192574589152 |
| cortical actin cytoskeleton (GO:0030864) | 0.0315192574589152 |
| integral to peroxisomal membrane (GO:0005779) | 0.0315192574589152 |
| intrinsic to peroxisomal membrane (GO:0031231) | 0.0315192574589152 |
| neural tube formation (GO:0001841) | 0.0315192574589152 |
| response to wounding (GO:0009611) | 0.0315594240025605 |
| protein histidine kinase activity (GO:0004673) | 0.0315594240025605 |
| peroxisome fission (GO:0016559) | 0.0315594240025605 |
| FACIT collagen (GO:0005593) | 0.0315594240025605 |
| fibroblast growth factor receptor activity (GO:0005007) | 0.0315594240025605 |
| nucleoside transport (GO:0015858) | 0.0315594240025605 |
| stem cell differentiation (GO:0048863) | 0.0315594240025605 |
| response to copper ion (GO:0046688) | 0.0315594240025605 |
| cholesterol efflux (GO:0033344) | 0.0315594240025605 |
| compartment specification (GO:0007386) | 0.0315594240025605 |
| protein-arginine N-methyltransferase activity (GO:0016274) | 0.0315594240025605 |
| positive regulation of axon extension (GO:0045773) | 0.0315594240025605 |
| morphogenesis of a polarized epithelium (GO:0001738) | 0.0315594240025605 |
| reproductive behavior (GO:0019098) | 0.0315594240025605 |
| transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185) | 0.0315594240025605 |
| autophagic vacuole (GO:0005776) | 0.0315594240025605 |
| glycogen catabolic process (GO:0005980) | 0.0315594240025605 |
| transforming growth factor beta receptor activity, type I (GO:0005025) | 0.0315594240025605 |
| internal side of plasma membrane (GO:0009898) | 0.0315594240025605 |
| arginine N-methyltransferase activity (GO:0016273) | 0.0315594240025605 |
| integral to mitochondrial membrane (GO:0032592) | 0.0315594240025605 |
| sheet-forming collagen (GO:0030935) | 0.0315594240025605 |
| paraxial mesoderm development (GO:0048339) | 0.0315594240025605 |
| troponin complex (GO:0005861) | 0.0315594240025605 |
| phosphatidylinositol transporter activity (GO:0008526) | 0.0315594240025605 |
| protein phosphorylated amino acid binding (GO:0045309) | 0.0315594240025605 |
| ribonucleotide catabolic process (GO:0009261) | 0.0315594240025605 |
| mating behavior (GO:0007617) | 0.0315594240025605 |
| negative regulation of axonogenesis (GO:0050771) | 0.0315594240025605 |
| negative regulation of locomotion (GO:0040013) | 0.0325926169471634 |
| maintenance of cellular protein localization (GO:0032507) | 0.0325926169471634 |
| response to toxin (GO:0009636) | 0.0325926169471634 |
| protein homooligomerization (GO:0051260) | 0.0325926169471634 |
| enzyme inhibitor activity (GO:0004857) | 0.0325926169471634 |
| insoluble fraction (GO:0005626) | 0.0325926169471634 |
| drug binding (GO:0008144) | 0.0325926169471634 |
| axoneme (GO:0005930) | 0.0325926169471634 |
| two-component sensor activity (GO:0000155) | 0.0325926169471634 |
| spindle (GO:0005819) | 0.0325926169471634 |
| covalent chromatin modification (GO:0016569) | 0.0333612872458413 |
| lyase activity (GO:0016829) | 0.0333612872458413 |
| nucleocytoplasmic transport (GO:0006913) | 0.0335191436820946 |
| oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616) | 0.0335191436820946 |
| hormone metabolic process (GO:0042445) | 0.0341082754658098 |
| regulation of phosphorylation (GO:0042325) | 0.0344286818600332 |
| regulation of I-kappaB kinase/NF-kappaB cascade (GO:0043122) | 0.0346840283920938 |
| cellular macromolecule catabolic process (GO:0044265) | 0.035968927825662 |
| feeding behavior (GO:0007631) | 0.035968927825662 |
| monosaccharide metabolic process (GO:0005996) | 0.0380724413688293 |
| regulation of protein binding (GO:0043393) | 0.0400894719032046 |
| acidic amino acid transport (GO:0015800) | 0.0400894719032046 |
| glial cell development (GO:0021782) | 0.0400894719032046 |
| sterol transporter activity (GO:0015248) | 0.0400894719032046 |
| regulation of striated muscle development (GO:0016202) | 0.0400894719032046 |
| cortical actin cytoskeleton organization and biogenesis (GO:0030866) | 0.0400894719032046 |
| cadherin binding (GO:0045296) | 0.0400894719032046 |
| negative regulation of protein transport (GO:0051224) | 0.0400894719032046 |
| L-glutamate transport (GO:0015813) | 0.0400894719032046 |
| nucleobase, nucleoside, nucleotide and nucleic acid transport (GO:0015931) | 0.0404298583071759 |
| caveola (GO:0005901) | 0.0404298583071759 |
| lipoprotein binding (GO:0008034) | 0.0404298583071759 |
| circadian rhythm (GO:0007623) | 0.0404298583071759 |
| amine transmembrane transporter activity (GO:0005275) | 0.0404298583071759 |
| regulation of microtubule polymerization or depolymerization (GO:0031110) | 0.0404298583071759 |
| symporter activity (GO:0015293) | 0.0414586383619246 |
| regulation of gene expression, epigenetic (GO:0040029) | 0.0420856558299715 |
| nuclear transport (GO:0051169) | 0.0423630213314064 |
| peptidyl-tyrosine phosphorylation (GO:0018108) | 0.0424884300726274 |
| response to nutrient (GO:0007584) | 0.0424884300726274 |
| menstrual cycle process (GO:0022602) | 0.0428060396157701 |
| glutamine metabolic process (GO:0006541) | 0.0428060396157701 |
| gluconeogenesis (GO:0006094) | 0.0428060396157701 |
| maintenance of cellular localization (GO:0051651) | 0.0428060396157701 |
| neural plate development (GO:0001840) | 0.0436015969474869 |
| clathrin coat of trans-Golgi network vesicle (GO:0030130) | 0.0436015969474869 |
| low-density lipoprotein binding (GO:0030169) | 0.0436015969474869 |
| intra-Golgi vesicle-mediated transport (GO:0006891) | 0.0436015969474869 |
| cholesterol binding (GO:0015485) | 0.0436015969474869 |
| regulation of protein catabolic process (GO:0042176) | 0.0436015969474869 |
| amino acid transport (GO:0006865) | 0.0436015969474869 |
| calcium ion transport (GO:0006816) | 0.0439219343808228 |
| regulation of multicellular organism growth (GO:0040014) | 0.0439219343808228 |
| glutamate signaling pathway (GO:0007215) | 0.0439219343808228 |
| lactation (GO:0007595) | 0.0439219343808228 |
| mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 0.0439219343808228 |
| ER-nuclear signaling pathway (GO:0006984) | 0.0439219343808228 |
| nuclear envelope (GO:0005635) | 0.0450021451487876 |
| nuclear organization and biogenesis (GO:0006997) | 0.0473475878520644 |
| negative regulation of growth (GO:0045926) | 0.0485060912682202 |
| Rho guanyl-nucleotide exchange factor activity (GO:0005089) | 0.0487063510203204 |
| regulation of translation (GO:0006417) | 0.0487696299420701 |
